Smoking, the xenobiotic pathway, and clubfoot

Amy Sommer1, Susan H Blanton, Katelyn Weymouth

  • 1Department of Pediatrics, University of Texas Medical School at Houston, 6431 Fannin Street, Houston, TX 77030, USA.

Insights

Genetic variations in xenobiotic metabolism genes are unlikely to be a major cause of clubfoot, though pathway disruption may contribute. This study investigated genetic factors influencing this common birth defect.

Area of Science:

  • Genetics
  • Orthopedics
  • Developmental Biology

Background:

  • Clubfoot is a common orthopedic birth defect affecting newborns globally.
  • Its etiology is multifactorial, with maternal smoking identified as a risk factor.
  • Genetic susceptibility, particularly in xenobiotic metabolism genes, is hypothesized to interact with environmental factors.

Purpose of the Study:

  • To investigate the association between genetic variations in xenobiotic metabolism genes and the risk of clubfoot.
  • To explore potential interactions between these genes and maternal smoking in clubfoot etiology.

Main Methods:

  • Genotyping of 22 single-nucleotide polymorphisms and two null alleles in eight xenobiotic metabolism genes (CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX1, NAT2, GSTM1, and GSTT1).
  • Analysis of a dataset comprising non-Hispanic white and Hispanic families with and without multiple affected individuals (multiplex and simplex).
  • Transmission disequilibrium tests and interaction analyses were performed.

Main Results:

  • Significant altered transmission was observed for rs1048943/CYP1A1 in aggregate and multiplex non-Hispanic white datasets.
  • A significant interaction was found between EPHX1 and NAT2.
  • CYP1A2 showed significant maternal and fetal genotypic effects, suggesting a negative impact on limb development.
  • No association was found between maternal smoking status and xenobiotic metabolism gene variations.

Conclusions:

  • Xenobiotic metabolism genes are unlikely to be a primary factor in clubfoot development.
  • Perturbation within this metabolic pathway may still play a contributory role in clubfoot etiology.
  • Further research is warranted to fully elucidate the genetic and environmental contributions to clubfoot.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation